Michael Morneau

VP Finance & CAO, Trius Therapeutics Inc.

Companies

Viking TherapeuticsVP, Finance and Administration May 8, 2018 to Jan 19, 2021¹
Viking TherapeuticsChief financial officer Apr 28, 2015 to Jan 23, 2018²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARViking Therapeutics, VP, Finance and Administration
2
SEC EDGARViking Therapeutics, Chief financial officer